Medicare Enrolled

Dr. Lindsey Cunningham, MSN, APRN, FNP-C

Neurology · Southlake, TX
Low-engagement
175 STONEBRIDGE LN STE 100, Southlake, TX 76092
8174212905
In practice since 2016 (9 years)
NPI: 1538513973 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 3 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Cunningham from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Cunningham? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Cunningham

Dr. Lindsey Cunningham is a neurology in Southlake, TX, with 9 years in practice.

Between the years covered by Open Payments, Dr. Cunningham received a total of $11,470 from 73 pharmaceutical and/or device companies across 762 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in neurology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Cunningham is Moderate — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 9 years in practice$ $11,470 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$11,470
Total received (2018-2024)
Avg $2,294/year across 5 years
Top 25% in TX for neurology
73
Companies
762
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$11,436 (99.7%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$33 (0.3%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,971
2023
$2,634
2022
$4,356
2021
$1,392
2018
$117

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Inspire Medical Systems, Inc.
$1,708
ABBVIE INC.
$1,204
Genentech USA, Inc.
$858
SK Life Science, Inc.
$500
UCB, Inc.
$426
EMD Serono, Inc.
$426
Harmony Biosciences LLC
$408
PFIZER INC.
$399
Lilly USA, LLC
$364
Biohaven Pharmaceutical Holding Company Ltd.
$326
Teva Pharmaceuticals USA, Inc.
$309
Biogen, Inc.
$304
IMPEL PHARMACEUTICALS INC.
$288
Biohaven Pharmaceuticals, Inc.
$234
Alexion Pharmaceuticals, Inc.
$208
HARMONY BIOSCIENCES LLC
$203
Sumitomo Pharma America, Inc.
$197
Axsome Therapeutics, Inc.
$190
Lundbeck LLC
$189
ARGENX US, INC.
$170
Grifols USA, LLC
$145
AbbVie Inc.
$145
Amneal Pharmaceuticals LLC
$142
Merz Pharmaceuticals, LLC
$133
Jazz Pharmaceuticals Inc.
$130
Abbott Laboratories
$123
JAZZ PHARMACEUTICALS INC.
$110
Sunovion Pharmaceuticals Inc.
$107
UPSHER-SMITH LABORATORIES LLC
$99
Amgen Inc.
$96
Neurelis, Inc.
$85
Azurity Pharmaceuticals, Inc.
$78
Allergan, Inc.
$75
LivaNova USA, Inc.
$70
MITSUBISHI TANABE PHARMA AMERICA, INC.
$64
GENZYME CORPORATION
$54
Kyowa Kirin, Inc.
$49
Harmony Biosciences Llc
$47
Avion Pharmaceuticals
$47
IDORSIA PHARMACEUTICALS US INC
$45
ANI Pharmaceuticals, Inc.
$37
EISAI INC.
$36
CATALYST PHARMACEUTICALS, INC.
$33
Arbor Pharmaceuticals, Inc.
$31
AstraZeneca Pharmaceuticals LP
$29
ACADIA Pharmaceuticals Inc
$28
Otsuka America Pharmaceutical, Inc.
$27
Horizon Therapeutics plc
$27
Mallinckrodt Hospital Products Inc.
$26
REVANCE THERAPEUTICS, INC.
$26
MDD US Operations, LLC
$24
Mitsubishi Tanabe Pharma America, Inc.
$22
GE HEALTHCARE
$21
Avadel CNS Pharmaceuticals, LLC
$21
Novartis Pharmaceuticals Corporation
$21
BANNER LIFE SCIENCES, LLC
$21
SCILEX PHARMACEUTICALS INC.
$21
Acorda Therapeutics, Inc
$21
CSL Behring
$21
Supernus Pharmaceuticals, Inc.
$20
Eisai Inc.
$19
Almatica Pharma LLC
$18
ZOLL Respicardia, Inc.
$18
Aucta Pharmaceuticals, Inc.
$18
Novo Nordisk Inc
$17
Ipsen Biopharmaceuticals, Inc
$16
Averitas Pharma Inc.
$16
TG THERAPEUTICS, INC.
$15
Catalyst Pharmaceuticals, Inc.
$14
GRT US Holding, Inc.
$14
Merck Sharp & Dohme LLC
$14
Adamas Pharmaceuticals, Inc.
$12
Collegium Pharmaceutical, Inc.
$12
Top 3 companies account for 32.9% of total payments
Associated products mentioned in payments ›
ACTHAR · ADUHELM · AJOVY · AMYVID · APTIOM · AUBAGIO · AUSTEDO · Aimovig · Austedo XR · BAFIERTAM · BELSOMRA · BOTOX · BRILINTA · BRIUMVI · Briviact · CREXONT · DAXXIFY · DYSPORT · Dhivy · ELYXYB - celecoxib · EMGALITY · Enspryng · FIRDAPSE · FYCOMPA · Fintepla · Fycompa · GOCOVRI · Gamunex-C · HORIZANT · Hizentra · Horizant · INBRIJA · INFINITY · INSPIRE · Inspire Upper Airway Stimulation System · KESIMPTA · KISUNLA · LUMRYZ · Leqembi · MAVENCLAD · Mavenclad · Motpoly XR · NAPRELAN · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nourianz · OCREVUS · OCTAGAM IMMUNE GLOBULIN (HUMAN) · ONGENTYS 50MG CAPSULES 30 · Ocrevus · Ozempic · PANZYGA · PURIFIED CORTROPHIN GEL · QULIPTA · QUTENZA · QUVIVIQ · Qutenza · RADICAVA · REXULTI · RYTARY · Rystiggo · SOLIRIS · SUNOSI · Soliris · Sunosi · TOSYMRA · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · UPLIZNA · VALTOCO · VNS THERAPY SENTIVA MODEL 1000 GENERATOR · VUMERITY · VYEPTI · VYVGART · VYVGART HYTRULO · Vimpat · WAKIX · Wakix · XCOPRI · XYWAV · Xeomin · ZEMBRACE SYMTOUCH · ZTLido · remede System
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for a neurology in Southlake?
Compare neurologys in the Southlake area by procedure volume, costs, and industry payment transparency.
Browse neurologys nearby

Geographic Context

Neurologys within 10 mi
244
Per 100K population
11.4
County median income
$81,905
Nearest hospital
TEXAS HEALTH HARRIS METHODIST HOSPITAL SOUTHLAKE
0.0 mi

Data Sources

Provider Registry NPPESWeekly updates
Medicare Enrollment PECOSMonthly updates
Practice Data— No dataN/A
Industry Payments Open PaymentsCY 2024
Disciplinary History— Not publicN/A

This provider has data in 3 of 4 available federal datasets, with a Data Coverage level of Moderate. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Cunningham is a neurology, and low-engagement industry engagement.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Does Dr. Cunningham receive payments from pharmaceutical companies?
Yes. Dr. Cunningham received a total of $11,470 from 73 companies across 762 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Dr. Cunningham) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →